Since VEGF is a therapeutic target for wet age-related macular degeneration (AMD) in patients, we were interested whether PP-001 could also suppress VEGF secretion by human retinal pigment epithelial cells, which are the major source of VEGF in AMD. This evidence concerns the gene VEGFA and wet macular degeneration.